Literature DB >> 22326450

Adenoma-carcinoma sequence in intrahepatic cholangiocarcinoma.

André Costa Pinho1, Renato Bessa Melo, Manuel Oliveira, Marinho Almeida, Joanne Lopes, Luís Graça, J Costa-Maia.   

Abstract

INTRODUCTION: Cholangiocarcinoma is a rare tumor but recent data report a worldwide increase in incidence and mortality. There are several risk factors associated with cholangiocarcinoma, and chronic inflammation of billiary tree seems to be implied in the cholangiocarcinogenesis, but little is known about this process. PRESENTATION OF CASE: We present a 56-year-old female with a bile duct adenoma incidentally discovered in the follow up of breast cancer that 18 months later progress to intrahepatic cholangiocarcinoma. DISCUSSION: This is a rare presentation of intrahepatic cholangiocarcinoma that suggests the classic adenoma-carcinoma sequence in cholangiocarcinogenesis. Furthermore this case gives rise to some questions about the possible common ground on intrahepatic cholangiocarcinoma and breast cancer.
CONCLUSION: Cholangiocarcinogenesis is a complex multi-step mechanism and further investigations are needed to fully understand this process. Copyright Â
© 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22326450      PMCID: PMC3282251          DOI: 10.1016/j.ijscr.2012.01.002

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  10 in total

1.  Tamoxifen-mediated growth inhibition of human cholangiocarcinoma.

Authors:  L K Sampson; S M Vickers; W Ying; J O Phillips
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.

Authors:  Domenico Alvaro; Barbara Barbaro; Antonio Franchitto; Paolo Onori; Shannon S Glaser; Gianfranco Alpini; Heather Francis; Luca Marucci; Paola Sterpetti; Stefano Ginanni-Corradini; Andrea Onetti Muda; David E Dostal; Adriano De Santis; Adolfo F Attili; Antonio Benedetti; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 3.  Intrahepatic cholangiocarcinoma: new insights in pathology.

Authors:  Christine Sempoux; Ghalib Jibara; Stephen C Ward; Cathy Fan; Lihui Qin; Sasan Roayaie; M Isabel Fiel; Myron Schwartz; Swan N Thung
Journal:  Semin Liver Dis       Date:  2011-02-22       Impact factor: 6.115

Review 4.  Bile duct adenoma. A study of 152 cases.

Authors:  G S Allaire; L Rabin; K G Ishak; I A Sesterhenn
Journal:  Am J Surg Pathol       Date:  1988-09       Impact factor: 6.394

Review 5.  Intrahepatic cholangiocarcinoma arising in multiple bile duct hamartomas: report of two cases and review of the literature.

Authors:  Ai-Min Xu; Zhi-Hong Xian; Shu-Hui Zhang; Xin-Fang Chen
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-05       Impact factor: 2.566

6.  Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.

Authors:  Joon Seon Song; Young-Joo Lee; Kyoung Won Kim; Jooryung Huh; Se Jin Jang; Eunsil Yu
Journal:  Pathol Int       Date:  2008-08       Impact factor: 2.534

7.  New advances in the management of biliary tract cancer.

Authors:  John Bridgewater; Charles Imber
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 8.  Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.

Authors:  David Schottenfeld; Jennifer Beebe-Dimmer
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

9.  Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.

Authors:  S A Khan; M B Toledano; S D Taylor-Robinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

10.  Molecular pathogenesis of cholangiocarcinoma.

Authors:  G Fava; I Lorenzini
Journal:  Int J Hepatol       Date:  2011-07-21
  10 in total
  7 in total

1.  Utility of DNA flow cytometry in distinguishing between malignant and benign intrahepatic biliary lesions.

Authors:  Kwun Wah Wen; Peter S Rabinovitch; Dongliang Wang; Aras N Mattis; Linda D Ferrell; Won-Tak Choi
Journal:  Virchows Arch       Date:  2020-04-15       Impact factor: 4.064

2.  Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Authors:  Mark Ettel; Ogechukwu Eze; Ruliang Xu
Journal:  World J Hepatol       Date:  2015-11-08

Review 3.  What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?

Authors:  Yasuni Nakanuma; Akemi Tsutsui; Xiang Shan Ren; Kenichi Harada; Yasunori Sato; Motoko Sasaki
Journal:  Int J Hepatol       Date:  2014-04-22

Review 4.  Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma.

Authors:  Kyoung-Bun Lee
Journal:  Clin Mol Hepatol       Date:  2016-09

Review 5.  Precursor Lesions of Cholangiocarcinoma: A Clinicopathologic Review.

Authors:  Bita Geramizadeh
Journal:  Clin Pathol       Date:  2020-06-15

Review 6.  Biliary Duct Hamartomas: A Systematic Review.

Authors:  Abdul Ahad E Sheikh; Anthony P Nguyen; Katarina Leyba; Nismat Javed; Sana Shah; Alexander Deradke; Christopher Cormier; Rahul Shekhar; Abu Baker Sheikh
Journal:  Cureus       Date:  2022-05-26

7.  Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation-like Feature Associated with Bile Duct Adenoma.

Authors:  Ah-Young Kwon; Hye Jin Lee; Hee Jung An; Haeyoun Kang; Jin-Hyung Heo; Gwangil Kim
Journal:  J Pathol Transl Med       Date:  2015-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.